<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Ross CR</submitter><pubmed_abstract>Metastasis remains a major cause of cancer mortality. AbstractThis study, expanding upon previous findings in the MMTV-PyMT model, investigated four independent mouse models, representing luminal (MMTV-PyMT, MMTV-Myc), HER2-amplified (MMTV-Her2) and triple negative (C3(1)TAg) breast cancer subtypes. Consistent with previous results, limited evidence for metastasis-associated somatic point mutations was found for all models. We also found that oncogenic drivers significantly influenced the number and size of metastasis-specific copy number variations (MSCNVs), but common driver-independent MSCNVs were rare. Furthermore, analyzing a cohort with varying genetic backgrounds while maintaining a constant oncogenic driver (PyMT) revealed that genetic background profoundly impacts MSCNVs. Transcri</pubmed_abstract><journal>bioRxiv : the preprint server for biology</journal><pagination>2025.01.15.633216</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12478397</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Investigating the genomic landscape of mouse models of breast cancer metastasis.</pubmed_title><pmcid>PMC12478397</pmcid><pubmed_authors>Ross CR</pubmed_authors><pubmed_authors>Qiu T</pubmed_authors><pubmed_authors>Hunter KW</pubmed_authors><pubmed_authors>Szczepanek K</pubmed_authors><pubmed_authors>Sanford J</pubmed_authors><pubmed_authors>Pearce L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Investigating the genomic landscape of mouse models of breast cancer metastasis.</name><description>Metastasis remains a major cause of cancer mortality. AbstractThis study, expanding upon previous findings in the MMTV-PyMT model, investigated four independent mouse models, representing luminal (MMTV-PyMT, MMTV-Myc), HER2-amplified (MMTV-Her2) and triple negative (C3(1)TAg) breast cancer subtypes. Consistent with previous results, limited evidence for metastasis-associated somatic point mutations was found for all models. We also found that oncogenic drivers significantly influenced the number and size of metastasis-specific copy number variations (MSCNVs), but common driver-independent MSCNVs were rare. Furthermore, analyzing a cohort with varying genetic backgrounds while maintaining a constant oncogenic driver (PyMT) revealed that genetic background profoundly impacts MSCNVs. Transcri</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-05-07T03:23:29.8Z</modification><creation>2026-05-07T03:12:55.587Z</creation></dates><accession>S-EPMC12478397</accession><cross_references><pubmed>41031038</pubmed><doi>10.1101/2025.01.15.633216</doi></cross_references></HashMap>